Abstract
Molecular and genetic breakthroughs continue to explode our knowledge of the limb-girdle muscular dystrophies. Despite a common, basic phenotype, the more than 25 genes underlying these genetic muscle diseases lead to substantial heterogeneity in pathogenesis and clinical course. Distinctive clinical, laboratory, and biopsy features often help to distinguish among them. Treatment remains predominantly supportive with excitement surrounding the genetic-based therapies.
Original language | English (US) |
---|---|
Title of host publication | Encyclopedia of the Neurological Sciences |
Publisher | Elsevier Inc. |
Pages | 890-896 |
Number of pages | 7 |
ISBN (Electronic) | 9780123851574 |
ISBN (Print) | 9780123851581 |
DOIs | |
State | Published - Jan 1 2014 |
Externally published | Yes |
Keywords
- Anoctamin
- Calpain
- Caveolin
- Creatine kinase
- Dysferlin
- Fukutin-related protein
- Lamin A/C
- Limb-Girdle muscular dystrophy
- Muscle biopsy
- Sarcoglycan
- Telethonin
- Titin
- α-Dystroglycan
ASJC Scopus subject areas
- General Medicine